Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 May 24;5(2):119-122.
doi: 10.15420/cfr.2018.39.2. eCollection 2019 May.

Diet, the Gut Microbiome and Heart Failure

Affiliations
Review

Diet, the Gut Microbiome and Heart Failure

Sivadasanpillai Harikrishnan. Card Fail Rev. .

Abstract

The collection of microorganisms that live in coexistence within or on the host body has been referred to as the microbiota. In humans, such cohabitation is mostly seen in the gut, mainly in the colon. The gut microbiome is acquired from the environment and is modified mostly by the diet. There are preliminary data to show that gut microbia can directly influence the pathogenetic disease processes in heart failure (HF). HF leads to bowel wall oedema and regional hypoxia, causing a change in the microbial flora of the gut, which can initiate or perpetuate certain pathogenetic process in HF. The structural component of the microbiota itself, such as lipopolysaccharides or the substances produced by the bacteria, such as trimethylamine N-oxide, is implicated in the pathogenesis of HF. This process is termed as the 'heart-gut axis' in HF. Manipulating the gut microbia or targeting products from the microbia may become treatment options for HF in future.

Keywords: Heart failure; gut microbia; lipopolysaccharide.; microbiota; trimethylamine N-oxide.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The author has no conflicts of interest to disclose.

Figures

Figure 1:
Figure 1:. Hypothesis of the Heart–Gut Axis in Heart Failure

Similar articles

Cited by

References

    1. Tang WH, Kitai T, Hazen SL. Gut microbiota in cardiovascular health and disease. Circ Res. 2017;120:1183–96. doi: 10.1161/CIRCRESAHA.117.309715. - DOI - PMC - PubMed
    1. Brown JM, Hazen SL. Microbial modulation of cardiovascular disease. Nat Rev Microbiol. 2016;16:171–81. doi: 10.1038/nrmicro.2017.149. - DOI - PMC - PubMed
    1. Tang WW, Hazen SL. Dietary metabolism, gut microbiota and acute heart failure. Heart. 2016;102:813–4. doi: 10.1136/heartjnl-2016-309268. - DOI - PMC - PubMed
    1. Tang WH, Hazen SL. The contributory role of gut microbiota in cardiovascular disease. J Clin Invest. 2014;124:4204–11. doi: 10.1172/JCI72331. - DOI - PMC - PubMed
    1. Jakobsson HE, Abrahamsson TR, Jenmalm MC et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by Caesarean section. Gut. 2014;63:559–66. doi: 10.1136/gutjnl-2012-303249. - DOI - PubMed